Related Topics
Malaria deaths, once declining, have stalled, but there’s reason for hope
Infectious disease researcher Flaminia Catteruccia, who explores novel eradication methods in her lab and in the field, remains optimistic about defeating the notoriously complex disease.
Once a malaria patient, student now has sights set on stopping the deadly disease
Cyrianne Keutcha, PhD ’25, has been around malaria all her life, from growing up in a malaria-endemic country, to being infected herself, and now to studying the parasite in the lab.
Dyann Wirth receives lifetime achievement award for malaria research
Harvard Chan School's Dyann Wirth has received a top award from the Multilateral Initiative on Malaria Society for playing a pivotal role in the global fight against malaria.
Flaminia Catteruccia elected member of National Academy of Sciences
Flaminia Catteruccia, professor of immunology and infectious diseases at Harvard Chan School, has been elected as a member of the National Academy of Sciences.
Tackling malaria in Brazil
Since the start of her career, Marcia Castro has sought to use her research to inform policy change.
Sara Bleich, Christian Happi elected to National Academy of Medicine
Two faculty members from Harvard Chan School—Sara Bleich and Christian Happi—have been elected to the National Academy of Medicine.
Why are we seeing new malaria cases in the U.S.?
The Centers for Disease Control and Prevention recently reported several cases of locally acquired malaria in Florida and Texas—the first such cases in the U.S. in over two decades. Manoj Duraisingh explains the significance of the cases and…
Finding practical solutions to climate change’s health impacts
The wide-ranging health impacts of climate change, including food insecurity, migration, war, and the spread of infectious diseases—and practical solutions to address these problems—were the focus of a half-day symposium hosted by Harvard Chan School.
Africa health care successes, challenges highlighted at conference
A range of topics regarding health care in Africa—including mental health, malaria, financing, and vaccine research, development, and manufacturing—were examined at the first-ever Africa Health Conference at Harvard Chan School.
Is new malaria vaccine ‘world-changing’? Maybe.
Harvard Chan School's Dyann Wirth offers some thoughts on a new malaria vaccine and its potential impact.
